572 related articles for article (PubMed ID: 33028409)
21. Granulins rescue inflammation, lysosome dysfunction, and neuropathology in a mouse model of progranulin deficiency.
Root J; Mendsaikhan A; Nandy S; Taylor G; Wang M; Araujo LT; Merino P; Ryu D; Holler C; Thompson BM; Astarita G; Blain JF; Kukar T
bioRxiv; 2023 Apr; ():. PubMed ID: 37131734
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.
Filiano AJ; Martens LH; Young AH; Warmus BA; Zhou P; Diaz-Ramirez G; Jiao J; Zhang Z; Huang EJ; Gao FB; Farese RV; Roberson ED
J Neurosci; 2013 Mar; 33(12):5352-61. PubMed ID: 23516300
[TBL] [Abstract][Full Text] [Related]
23. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
[TBL] [Abstract][Full Text] [Related]
24. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression.
Khrouf W; Saracino D; Rucheton B; Houot M; Clot F; Rinaldi D; Vitor J; Huynh M; Heng E; Schlemmer D; Pasquier F; Deramecourt V; Auriacombe S; Azuar C; Levy R; Bombois S; Boutoleau-Brétonnière C; Pariente J; Didic M; Wallon D; Fluchère F; Auvin S; Younes IB; ; ; Nadjar Y; Brice A; Dubois B; Bonnefont-Rousselot D; Le Ber I; Lamari F
Neurobiol Dis; 2023 Jun; 181():106108. PubMed ID: 37003407
[TBL] [Abstract][Full Text] [Related]
25. Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia.
Simon MJ; Logan T; DeVos SL; Di Paolo G
Trends Cell Biol; 2023 Apr; 33(4):324-339. PubMed ID: 36244875
[TBL] [Abstract][Full Text] [Related]
26. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients.
Arrant AE; Davis SE; Vollmer RM; Murchison CF; Mobley JA; Nana AL; Spina S; Grinberg LT; Karydas AM; Miller BL; Seeley WW; Roberson ED
Ann Clin Transl Neurol; 2020 Dec; 7(12):2433-2449. PubMed ID: 33197149
[TBL] [Abstract][Full Text] [Related]
28. Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice.
Tanaka Y; Chambers JK; Matsuwaki T; Yamanouchi K; Nishihara M
Acta Neuropathol Commun; 2014 Jul; 2():78. PubMed ID: 25022663
[TBL] [Abstract][Full Text] [Related]
29. Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia.
Sung W; Noh MY; Nahm M; Kim YS; Ki CS; Kim YE; Kim HJ; Kim SH
J Neuroinflammation; 2024 Feb; 21(1):47. PubMed ID: 38347588
[TBL] [Abstract][Full Text] [Related]
30. Progranulin as a therapeutic target for dementia.
Galimberti D; Fenoglio C; Scarpini E
Expert Opin Ther Targets; 2018 Jul; 22(7):579-585. PubMed ID: 29889573
[TBL] [Abstract][Full Text] [Related]
31. Progranulin as a therapeutic target in neurodegenerative diseases.
Rhinn H; Tatton N; McCaughey S; Kurnellas M; Rosenthal A
Trends Pharmacol Sci; 2022 Aug; 43(8):641-652. PubMed ID: 35039149
[TBL] [Abstract][Full Text] [Related]
32. Chemical and genetic rescue of in vivo progranulin-deficient lysosomal and autophagic defects.
Doyle JJ; Maios C; Vrancx C; Duhaime S; Chitramuthu B; Bennett HPJ; Bateman A; Parker JA
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34140407
[TBL] [Abstract][Full Text] [Related]
33. Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice.
Frew J; Nygaard HB
Acta Neuropathol Commun; 2021 Apr; 9(1):57. PubMed ID: 33795008
[TBL] [Abstract][Full Text] [Related]
34. Core features of frontotemporal dementia recapitulated in progranulin knockout mice.
Ghoshal N; Dearborn JT; Wozniak DF; Cairns NJ
Neurobiol Dis; 2012 Jan; 45(1):395-408. PubMed ID: 21933710
[TBL] [Abstract][Full Text] [Related]
35. Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.
Huin V; Barbier M; Bottani A; Lobrinus JA; Clot F; Lamari F; Chat L; Rucheton B; Fluchère F; Auvin S; Myers P; Gelot A; Camuzat A; Caillaud C; Jornéa L; Forlani S; Saracino D; Duyckaerts C; Brice A; Durr A; Le Ber I
Brain; 2020 Jan; 143(1):303-319. PubMed ID: 31855245
[TBL] [Abstract][Full Text] [Related]
36. Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.
Zhou X; Kukar T; Rademakers R
Adv Exp Med Biol; 2021; 1281():219-242. PubMed ID: 33433878
[TBL] [Abstract][Full Text] [Related]
37. Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia.
Kurnellas M; Mitra A; Schwabe T; Paul R; Arrant AE; Roberson ED; Ward M; Yeh F; Long H; Rosenthal A
J Transl Med; 2023 Jun; 21(1):387. PubMed ID: 37322482
[TBL] [Abstract][Full Text] [Related]
38. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia.
Hsiao-Nakamoto J; Chiu CL; VandeVrede L; Ravi R; Vandenberg B; De Groot J; Tsogtbaatar B; Fang M; Auger P; Gould NS; Marchioni F; Powers CA; Davis SS; Suh JH; Alkabsh J; Heuer HW; Lago AL; Scearce-Levie K; Seeley WW; Boeve BF; Rosen HJ; Berger A; Tsai R; Di Paolo G; Boxer AL; Bhalla A; Huang F;
bioRxiv; 2024 Feb; ():. PubMed ID: 38405775
[TBL] [Abstract][Full Text] [Related]
39. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
[TBL] [Abstract][Full Text] [Related]
40. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice.
Tanaka Y; Matsuwaki T; Yamanouchi K; Nishihara M
Neuroscience; 2013 Oct; 250():8-19. PubMed ID: 23830905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
